Current Identification of Neoantigens & How this Translates to Preclinical Settings
Time: 12:00 pm
day: Track A - Day 1 AM
Details:
- Considering the current overview of identification and prioritisation of cancer neoantigens
- Highlighting the limitations of current neoantigen prediction pipelines
- Discussing broader challenges associated with cancer neoantigen vaccines
